| __timestamp | Amneal Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 449634000 | 13486000 |
| Thursday, January 1, 2015 | 499226000 | 46361000 |
| Friday, January 1, 2016 | 597455000 | 23654000 |
| Sunday, January 1, 2017 | 526178000 | 23484000 |
| Monday, January 1, 2018 | 716403000 | 20182000 |
| Tuesday, January 1, 2019 | 352997000 | 44734000 |
| Wednesday, January 1, 2020 | 628393000 | 16136000 |
| Friday, January 1, 2021 | 768973000 | 149906000 |
| Saturday, January 1, 2022 | 784708000 | 264233000 |
| Sunday, January 1, 2023 | 820565000 | 326751000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, Amneal Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have shown distinct trajectories in their gross profit over the past decade. Amneal Pharmaceuticals has consistently outperformed BioCryst, with its gross profit peaking at approximately $820 million in 2023, marking a 82% increase from 2014. In contrast, BioCryst Pharmaceuticals, while starting at a modest $13 million in 2014, has demonstrated impressive growth, reaching $327 million in 2023, a staggering 2,300% increase. This growth narrative highlights the dynamic nature of the pharmaceutical industry, where strategic innovation and market adaptation can lead to significant financial gains. As we delve into these figures, it becomes evident that while Amneal maintains a steady lead, BioCryst's rapid growth trajectory is a testament to its evolving market strategy.
Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: AbbVie Inc. and Amneal Pharmaceuticals, Inc. Trends
Gross Profit Analysis: Comparing Merck & Co., Inc. and Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing AstraZeneca PLC and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Viatris Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Ascendis Pharma A/S and Amneal Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Veracyte, Inc. and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis